Furthermore, endoglin, the protein mutated in HHT type 1, has been shown to suppress invasion and metastasis of breast cancer, with lower endoglin expression in the tumour compartment correlating with poorer clinical outcome [54]. The gene discussed is ENG; the disease is neoplasm.